$PRPM DD Relevant To Current Trading - Updated January 23,

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
514
$PRPM DD Relevant To Current Trading - Updated January 23, 2021.

[important items in bold]

Key Points From Recent Updates From November 27, 2020 Onwards

Basic Company / Ticker

- Shareholders notified that Facebook to be considered as a source of publicly available information (therefore meeting the SEC requirement) in addition to formal PRs.

- Moving to get otcmarkets.com to upgrade $PRPM from "STOP - Pink No Information" to " YIELD - Pink Limited Information" [although the "STOP" sign has not inhibited top OTC traders of $PRPM from making multiple $5-figure profits already in just the last few weeks as they use OTC-friendly brokers].

- Working on getting filings up to date - all 5 years in a single upload - and getting upgraded to "OTC Pink Current" - then the next tier - then "Fully Reporting" - then the "big boards".

- Already "in good standing" with the WY SOS and all the regulatory agencies: FINRA, SEC,DTCC and OTC Markets.

- Reduction in Authorized Shares count - of at least 5 Billion - planned.

- Outstanding Shares count will also be reduced.

- Several blocks of shares "in reserve" will be surrendered back to the treasury.

- Not planning or contemplating a reverse stock split.

- There is no intent or ability to dilute the share structure - in any event additional stock cannot be deposited with a "STOP" sign in force.

- CEO owns 1+ Billion shares but they are in certificate form and locked up so that brokers and traders cannot short, borrow or trade against them.

- CEO also cannot sell his shares - which he doesn't want to off course with all that is ahead - because he is an "Affiliate".

- Nonsense on amateur trading forums debunked. For instance, the CEO is not a convicted felon - and couldn't be otherwise he wouldn't be allowed to be a registered gun owner in TX. He also has a concealed carry permit which you can't have in TX if you have any criminal record.

Near Term Developments

- Final and approved "White Paper" on software to be posted soon.

- Announcement of an informational website launch as soon as the software and the App is published and becomes available on Google Play and Apple Store. Name will be published in the PR.

- There will be several license agreements for all the sister companies - branded separately.

- The software revenue stream will come not only from the company's own internal use but also from use as a stand alone processing tool.

- $PRPM will receive a commission as each transaction occurs - similar to the way in which credit card processing companies and banks charge when consumers use them.

Update - December 29

https://investorshangout.com/post/view?id=6002400

Update - December 31 - Deal Closed:

https://investorshangout.com/post/view?id=6005368

Update - January 9 - OTC Current Soon:

https://investorshangout.com/post/view?id=6013610

Update - January 21 - Acquisition PR Week January 25 On - Valuation .0010 > .0050

https://investorshangout.com/post/view?id=6026806

Social Media Updates

https://www.facebook.com/MJVentureCapital/

Share Structure - Updated January 22, 2020

Transfer Agent Verified.

No change - no dilution confirmed.

Authorized Shares: 16,000,000,000

Outstanding Shares: 10,821,252,428

Restricted: 89,273,470

Unrestricted: 10,731,978,958

Held At DTC: 10,565,876,856

Note: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.

Recent Trading

Nov 27: .0001 > .0004 bought out and .0005 started - 400%

Nov 30: .0004 > .0008 - 100%

Dec 1: .0006 > .0016 - 167%

Dec 2: .0005 > .0010 - 100%

Dec 11: .0003 > .all .0005s bought out - 66%

Dec 24: .0003 > .0005 - 66%

Dec 28: .0003 > .0004 - 33%

Dec 30: .0003 > .0004 - 33%

Dec 31: .0003 > .0004 - 33%

Jan 4: .0003 > .0004 - 33%

Jan 5: .0003 > .0004 - 33%

Jan 6: .0003 > .0004 - 33%

Jan 7: .0004 > .0006 - 50%

Jan 8: .0005 > .0006 - 20%

Jan 11: .0004 > .0007 - 75%

Jan 12: .0004 > .0006 - 50%

Jan 13: .0004 > .0005 - 25%

Jan 14: .0004 > .0005 - 25%

Jan 15: .0004 > .0006 - 50%

Jan 19: .0004 > .0006 - 50%

Jan 20: .0004 > .0005 - 25%

Jan 21: .0004 > .0006 - 50%

Jan 22: .0005 > .0008 - 60%

Average daily volume Dec 1 - Jan 22 (36 days): 11,685M / 36 = 325M

Currently there is a loading opportunity at .0007/8.

For full-time day traders spending at least 10% of their day on it, $PRPM was the #7 Top Profit Earner of 2020 - multiple $5-figures - in just 29 trading days - again rewarding the patient, observant and decisive who ignore irrelevant factors.

It is already the #4 Top Profit Earner so far in 2021 in only 14 days - and of course only just getting started with uplisting to Q1 ahead.

Expect runs - into the .0010+ > .01 range - on multiple catalysts ahead - including an acquisition deal closing PR / filing imminently.

Company Contacts:

E-mail: ev24903@gmail.com

Cell: 214-418-6940



ProTek Capital Inc. (PRPM) Stock Research Links

PRPM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CAE Boosts Fiscal 2027 Outlook; Transformation On Track

Updated Category News Views 116

Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...

Continue Reading
Ingram Micro Joins S&P SmallCap 600 Amid M&A Moves

Updated Category News Views 87

Market Shufflin’ as Ingram Micro Steps In The constant ebb and flow of the stock market got right interesting with Ingram Micro Holding Corp. (NYSE: INGM) slated to crawl into the S&P SmallCap 600. This dance change-up is all thanks to Viatris Inc. (NASD: VTRS) looking to wrap up its acquisition of Pacira BioSciences (NASD: PCRX). With this deal sealing the fate of...

Continue Reading
'Luz de las Naciones' Event: A Cultural Milestone

Updated Category News Views 67

A Vibrant Showcase of Culture and Faith Grab your seatbelt, because when you hear about a cultural event lighting up the scene, especially one backed by The Church of Jesus Christ of Latter-day Saints, it means something's brewing. We're diving headfirst into 'Luz de las Naciones,' a celebration that's keeping its promise to highlight Latin America's zest and vibrant...

Continue Reading
Elron Ventures Advances Dual-Use Tech Investment Plans

Updated Category News Views 19

A Strategic Dance through Conferences Elron Ventures is gearing up for an action-packed November slate, aiming to flaunt its prowess in investment across burgeoning tech fields like Defense Tech, Deep Tech, Cybersecurity, and AI. Now, any seasoned investor knows these are the buzzy sectors that could just be the workhorses pulling the future market cart. But what makes...

Continue Reading
GFL's Big Share Conversion: Impact and Implications

Updated Category News Views 0

Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...

Continue Reading
China's Double 11 Fest Rings in $264B in 2026

Updated Category News Views 8

Shifting Gears at the 2026 Double 11 Festival You blinked, and another record was shattered. China's "Double 11" Shopping Festival, with its rhythmic frenzy and relentless countdowns, clocked a staggering RMB 1,776.4 billion this year—roughly US$264.4 billion. This ain't no ordinary sale, it's a financial juggernaut, folks. As these platforms duke it out for every yuan,...

Continue Reading
DarioHealth Eyes Growth with Rising Revenue and Reduced Costs

Updated Category News Views 0

Quarterly Earnings Reflect Strategic Forward Movement This quarter, DarioHealth (NASDAQ: DRIO) decided to crank up the volume on its long-haul strategy. They've managed a respectable 6% revenue increase over last year, clocking in at $5.3 million for the third quarter of 2026. It's a slight nudge up from the previous quarter too, where they sat at $5.2 million. Not...

Continue Reading
Can BWIN, CCC, PCRX Deals Really Serve Shareholders?

Updated Category News Views 28

Shareholder Stakes: Caught in Controversy Well, here we go again. These days, it seems like shareholder lawsuits are cropping up as regularly as sunrise. We've got Halper Sadeh LLC on a warpath, targeting potential legal missteps in the megadeals involving Baldwin Group (NASDAQ:BWIN), CCC Intelligent Solutions Holdings (NASDAQ:CCC), and Pacira BioSciences (NASDAQ:PCRX)....

Continue Reading
Eli Radiopharma Clinches Big Series A, Eyes Milestones

Updated Category News Views 103

Making Waves in Radiopharmaceuticals Some days, it's not just about the numbers—it’s about the shift in an entire field. Eli Radiopharma just closed a grand RMB 400 million Series A financing, paving a path that could redefine radiopharmaceuticals. Kinfolk over at Huagai Capital led the charge, teaming up with Bayland Capital and a throng of other backers. They’re...

Continue Reading
BSR REIT's Q3 2026 Financials: Strategic Progress Made

Updated Category News Views 57

BSR REIT Hits Strategic Milestones in Q3 Here's a bit of exciting news hitting us from BSR Real Estate Investment Trust. They've dropped their financial results for the third quarter of 2026. Packed with some solid gains, this quarter wasn't just about the numbers—it was about the moves they've been making underneath it all. So, let's break down what they're up to, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Indy Autonomous Challenge Unveils Multicar Racing at CES 2025

Updated Category News Views 312

Indy Autonomous Challenge Returns at CES 2025 The Indy Autonomous Challenge (IAC), a global leader in high-speed autonomy, is poised for an exciting return to CES 2025 with groundbreaking developments, including the introduction of multicar racing and advancements in physical AI. This event, taking place in January 2025 at the Las Vegas Motor Speedway, promises a...

Continue Reading
Veris Residential, Inc. Sets Webcast for Q2 2025 Financials

Updated Category News Views 200

Veris Residential, Inc. Plans Webcast for Q2 Financial Results Veris Residential, Inc. provides an exciting update for shareholders and potential investors. The company has announced it will host a webcast for its second quarter 2025 financial results. This marks an important opportunity for stakeholders to gain insights into the company's performance and future...

Continue Reading
Bank Expert Shares Tips for Effortless Checking Setup

Updated Category News Views 129

Streamlining Your Checking Account Setup Tossing out the right prep can turn opening a checking account from a headache to a breeze. Banking luminary Abigail White spills the beans in a HelloNation piece, shedding light on how getting your ducks in a row with documents and features puts you in the driver’s seat of financial well-being. The Basics: Identification and...

Continue Reading
Serabi Gold Announces Robust Mid-Year Financial Performance

Updated Category News Views 207

Serabi Gold Reports Strong Interim Results for 2024 Serabi Gold plc (LSE: SRB, TSX: SBI) has unveiled its unaudited financial results for the first half of 2024, demonstrating impressive growth and strategic investments during this period. Strong Financial Performance Clive Line, the Chief Financial Officer of Serabi Gold, emphasized the company's financial successes in...

Continue Reading
Innovative Strategies in Drug Development: A New Era with BullFrog AI

Updated Category News Views 190

Transforming Drug Development with Innovative AI Solutions From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence. In a market valued over $200 billion and saturated with black-box AI, BullFrog AI's bfLEAP™ stands out by offering biologically grounded analytics that steer strategic...

Continue Reading